- Home
- NBY vs PALI Comparison
NBY vs PALI Comparison
Compare NBY & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- PALI
- Stock Information
- Founded
- NBY 2000
- PALI 1996
- Country
- NBY United States
- PALI United States
- Employees
- NBY N/A
- PALI N/A
- Industry
- NBY
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NBY
- PALI Health Care
- Exchange
- NBY Nasdaq
- PALI Nasdaq
- Market Cap
- NBY 3.4M
- PALI 3.2M
- IPO Year
- NBY 2007
- PALI N/A
- Fundamental
- Price
- NBY $0.58
- PALI $0.72
- Analyst Decision
- NBY Strong Buy
- PALI Strong Buy
- Analyst Count
- NBY 1
- PALI 2
- Target Price
- NBY $0.85
- PALI $23.00
- AVG Volume (30 Days)
- NBY 67.8K
- PALI 45.4K
- Earning Date
- NBY 05-08-2025
- PALI 05-12-2025
- Dividend Yield
- NBY N/A
- PALI N/A
- EPS Growth
- NBY N/A
- PALI N/A
- EPS
- NBY N/A
- PALI N/A
- Revenue
- NBY $9,781,000.00
- PALI N/A
- Revenue This Year
- NBY $23.91
- PALI N/A
- Revenue Next Year
- NBY $32.05
- PALI N/A
- P/E Ratio
- NBY N/A
- PALI N/A
- Revenue Growth
- NBY N/A
- PALI N/A
- 52 Week Low
- NBY $0.36
- PALI $0.60
- 52 Week High
- NBY $9.10
- PALI $9.09
- Technical
- Relative Strength Index (RSI)
- NBY 50.71
- PALI 46.57
- Support Level
- NBY $0.56
- PALI $0.67
- Resistance Level
- NBY $0.60
- PALI $0.77
- Average True Range (ATR)
- NBY 0.04
- PALI 0.05
- MACD
- NBY 0.01
- PALI 0.02
- Stochastic Oscillator
- NBY 75.00
- PALI 54.90
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.